47 results on '"Li, Qingshui"'
Search Results
2. Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study
3. Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery
4. A phase III randomized, double-blinded, placebo-controlled study of suvemcitug combined with chemotherapy for platinum-resistant ovarian cancer (SCORES).
5. Efficacy and safety of combination therapy with envafolimab and lenvatinib in patients with endometrial cancer after failure of first-line platinum-based therapy.
6. The efficacy and safety of RC88 in patients with ovarian cancer, non-squamous-non-small-cell lung-carcinoma and cervical cancer: Results from a first-in-human phase 1/2 study.
7. Evaluation of the effectiveness and safety of disitamab vedotin in HER2-expressing 2L recurrent or metastatic cervical cancer (r/mCC): Interim results of RC48-C018.
8. Biomarker-driven targeted therapy in patients with recurrent platinum-resistant epithelial ovarian cancer (BRIGHT): protocol for an open-label, multicenter, umbrella study
9. Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, noninferiority, randomized controlled trial
10. EP323/#463 Efficacy and safety of mirvetuximab soravtansine in Chinese patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: results from IMGN853–301 (Soraya China) study
11. Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
12. Overexpression of tissue microRNA10b may help predict glioma prognosis
13. EP304/#313 Efficacy and safety of niraparib combined with oral etoposide in platinum resistant/refractory recurrent ovarian cancer: a multicentre, single arm, prospective phase II trial
14. Does the primary treatment sequence affect post‐relapse survival in recurrent epithelial ovarian cancer? A real‐world multicentre retrospective study
15. The first Chinese National Union of Real‐world Gynaecological Oncology Research and Patient Management Platform: A retrospective study
16. Additional file 1 of Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study
17. Study on Semantic Web Service Automatic Combination Technology Based on Agent
18. An Improved Association Rule Privacy Protection Algorithm Research
19. Applied Study of Fuzzy Clustering Algorithm in Invasion Detection
20. The Study of Improved Grid Resource Scheduling Algorithm
21. Effectiveness and safety of niraparib as neoadjuvant therapy in advanced ovarian cancer with homologous recombination deficiency: NANT study protocol for a prospective, multicenter, exploratory, phase 2, single-arm study (041)
22. Development and validation of a nomogram to predict overall survival of epithelial ovarian cancer patients: a population-based study (381)
23. Molecular insight into the π‐stacking interactions of human ovarian cancer PARP‐1 with its small‐molecule inhibitors and rational design of aromatic amino acid‐rich peptides to target PARP‐1 based on the π‐stacking network
24. Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial
25. Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial.
26. Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study
27. Propensity score matching analysis of ovarian cancer patients with multiple primary malignant neoplasms using multicenter real-world data.
28. Efficacy and safety of niraparib combined with oral etoposide in platinum-resistant/refractory ovarian cancer (PROC): a single arm, phase 2 study
29. The Study of Improved Grid Resource Scheduling Algorithm
30. Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
31. BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group
32. Radiosensitivity of human ovarian cancer cells is enhanced by pseudolaric acid B due to the inhibition of the Ras/Raf/ERK signaling pathway
33. Radiosensitivity of human ovarian cancer cells is enhanced by pseudolaric acid B due to the inhibition of the Ras/Raf/ERK signaling pathway.
34. Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial.
35. The study of personalized recommendation technology based content and project collaborative filtering combines
36. Study on the Application of Educational Technology in Education Reform
37. Data warehouse model design technology analysis and research
38. An Improved Personalized Recommendation System Research
39. The application research of extenics in association rules data mining
40. The study of wireless campus Mesh network route protocol design
41. Privacy preserving research based on association rule algorithm
42. Sparing of saphenous vein during inguinal lymphadenectomy for vulval malignancies
43. The application research of extenics in association rules data mining
44. Data warehouse model design technology analysis and research
45. Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study.
46. Does the primary treatment sequence affect post-relapse survival in recurrent epithelial ovarian cancer? A real-world multicentre retrospective study.
47. The first Chinese National Union of Real-world Gynaecological Oncology Research and Patient Management Platform: A retrospective study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.